NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Calkins K, Crabtree E, Harrison E, et al. Impact of COVID-19 on Clinical Trials Costs to Patients: Environmental Scan [Internet]. Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2024 Jun 25.
The authors wish to thank Sue Felt-Lisk, Chris Palo, Donovan Griffin, and Barbara Collette at Mathematica for their contributions to this work. We would also like to acknowledge the following individuals:
- Allison Kolbe, PhD, ASPE
- Trinidad Beleche, PhD, ASPE
- Deborah Porterfield, MD, MPH, ASPE
- Jessica White, MPP, ASPE
- Kathleen Miller, PhD MS, ASPE
- Contract Officer’s Representative, Marsha Clarke, PhD, ASPE
- Hope King, PhD, MSPH, Centers for Disease Control and Prevention
- Christine Lee, Pharm. D, PhD, Food and Drug Administration
- Winifred (Ann) Meeker-O’Connell, Food and Drug Administration
- Richard P. Moser, National Cancer Institute, National Institutes of Health
- Kelly Blake, SCD, National Cancer Institute, National Institutes of Health
- Courtney P. Williams, DrPH, University of Alabama at Birmingham